ModivCare (MODV) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Q3 2024 service revenue was $702 million, up 2.2% year-over-year, driven by growth in PCS and NEMT, while RPM declined; operational improvements and cost savings supported results.
Adjusted EBITDA was $43.2 million (6.2% margin), down 15.9% year-over-year, mainly due to higher utilization, contract attrition, and increased service expenses.
Net loss for Q3 2024 was $26.6 million (loss per share: $1.87), compared to $4.3 million in Q3 2023, primarily due to higher interest expense and an $11.8 million debt extinguishment loss.
The company amended its credit agreement for temporary covenant relief and refinanced $500 million in Senior Notes with a $525 million Term Loan Facility.
Substantial doubt exists about the company’s ability to meet obligations within one year due to extended receivables collection periods and covenant compliance risks.
Financial highlights
Q3 2024 revenue was $702 million, up 2.2% year-over-year; NEMT revenue up 1.3%, PCS up 4.7%, RPM down 1.7%.
Adjusted EBITDA was $43.2 million (6.2% of revenue), supported by strong PCS and RPM performance and NEMT cost savings.
Free cash flow for the quarter was $1.5 million; cash provided by operations was $9.3 million.
Q3 2024 operating income was $5.3 million (0.7% of revenue), down from $12 million in Q3 2023.
Interest expense increased by $10.6 million year-over-year; $11.8 million loss on debt extinguishment was recorded.
Outlook and guidance
2024 revenue guidance affirmed at $2.7–$2.9 billion; adjusted EBITDA guidance at $170–$180 million.
Adjusted EBITDA growth in excess of 10% is expected in 2025, driven by membership growth, new contracts, and cost savings.
Guidance excludes effects of future M&A or disposition activity and is based on the current operating environment.
More details on 2025 outlook to be provided with Q4 and full-year 2024 results.
Management is pursuing further amendments to debt covenants and additional liquidity measures but cannot assure success.
Latest events from ModivCare
- Q2 2024 revenue flat at $698.3M, net loss $128.9M, Adjusted EBITDA $45.4M, RPM impairment.MODV
Q2 20242 Feb 2026 - Margin expansion and digital transformation position the business for growth and stability.MODV
Jefferies Global Healthcare Conference1 Feb 2026 - Q2 2025 loss deepened to $303.7M amid bankruptcy, restructuring, and major goodwill impairment.MODV
Q2 202529 Dec 2025 - Chapter 11 restructuring confirmed; revenue and membership down, equity to be canceled.MODV
Q3 202529 Dec 2025 - Healthcare services firm files $200M shelf for flexible equity, debt, and warrant offerings.MODV
Registration Filing16 Dec 2025 - Revenue up 1.3% to $2.79B, but losses and margin pressures persist amid industry disruption.MODV
Q4 202412 Dec 2025 - $105M in new financing, board changes, and a strategic review aim to stabilize operations.MODV
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the 2025 annual meeting.MODV
Proxy Filing1 Dec 2025 - Stockholders to vote on $30M note issuance and $20.165M exchange to bolster financial position.MODV
Proxy Filing1 Dec 2025